chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2022 at 12:09 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 28-Jan-2022 at 12:09 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported Vaccines went into 28 degree Celsius thaw state on or about 24 Dec 2021.
I awakened at 2 am 6.22.19 following the 4 pm injection on 6.21.19.  I was aware of achiness and sweating at that point.  I slept much later than usual and awoke feeling as though I had the flu:  chilling, sweating, body aches, joints hurt, fatigue and lethargy.  This lasted for another 48 hours, with the first 24 hrs by far the worst with fever, etc.  By 6.23.19 at 4 pm, those signs had resolved. I noted prickling, burning, itching and tingling on left scapular area starting 6.23.19 at 12 noon.  This progressed into the evening, making it difficult to sleep for the discomfort.  This continued into today 6.24.19 but to a lesser degree.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2013, the patient was inoculated with ZOSTAVAX at a pharmacy for routine adult health maintenance and the intended purpose for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster, the very virus the ZOSTAVAX vaccine is intended to prevent. In 2016, the patient was treated by a physician for a vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Pt. reported that bodyaches started 8/21/18 - Tuesday. Took ALEVE at noon. Pt. said she could feel 'every bone in her body'. Persisted till Thursday. On Wednesday night couldn't sleep because of discomfort. Headaches, shoulder pain, back pain. Went to acupuncture Thursday and feels better now.
She experienced bad chills. She has had chills off and on.; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (She experienced bad chills. She has had chills off and on.) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 028H21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced CHILLS (She experienced bad chills. She has had chills off and on.). At the time of the report, CHILLS (She experienced bad chills. She has had chills off and on.) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD-2021-416098 (Patient Link).
Green PENTACEL vial (HIB) was mixed with normal saline and administered without the blue vial (DTAP) (IPV). Contacted manufacturer and a complete PENTACEL needs to be administered.
On 10/1, patient reported feeling itchy all over body, congestion, and pain at injection site. On 10/2, patient reported bright red and itchy hands and feet, as well as hives on forehead. Patient applied topical antihistamine cream to hands and feet, which relieved redness but not itching. As the day progressed, the patient developed full body itching, redness, and difficulty breathing. She was taken to the ED where steroids were administered.
cervical adenopathy, poss ear infect on lt, stiff neck w/some limitation of motion; tx Amantidine; superficial scratch on back of neck @ hairline by rabid fox; 8SEP92 pt recovered;
This spontaneous report was received from a nurse regarding a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not provided. On 15-AUG-2016, the patient was vaccinated with improperly stored dose of VARIVAX (lot # L042266, expiration date 27-OCT-2017, exact dose and route of administration were not reported). The administered dose experienced a temperature excursions of 11.5 degree Fahrenheit for 3 hours and 54 minutes. Previous temperature excursion was reported. The call was because of a data logger. No adverse effects were reported. This is one of the several reports received from the same source. Additional information has been requested.
could not sleep nor able to change the positions; diagnosis of Degenerative Narrowing on C5-6; loss of mobility in arm (no notation of R or L arm); felt pain in both shoulders around spine; Pain level max at 10/10 when patient was on medications; pain level lowered to 6/10 when patient took medications; Rashes began on both arms; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INTERVERTEBRAL DISC DEGENERATION (diagnosis of Degenerative Narrowing on C5-6), MOBILITY DECREASED (loss of mobility in arm (no notation of R or L arm)), INSOMNIA (could not sleep nor able to change the positions), RASH (Rashes began on both arms) and ARTHRALGIA (felt pain in both shoulders around spine) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Crohn's disease. Concomitant products included CHOLESTYRAMINE for Cholesterol, USTEKINUMAB (STELARA), MERCAPTOPURINE and ALLOPURINOL for Crohn's disease, BIOTIN, VITAMINS NOS (MVI [VITAMINS NOS]) and FERROUS SULFATE, FOLIC ACID (IRON FOLIC) for Supplementation therapy.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced RASH (Rashes began on both arms). On 05-Apr-2021, the patient experienced MOBILITY DECREASED (loss of mobility in arm (no notation of R or L arm)), ARTHRALGIA (felt pain in both shoulders around spine), PAIN (Pain level max at 10/10 when patient was on medications) and PAIN (pain level lowered to 6/10 when patient took medications). On 07-Apr-2021, the patient experienced INTERVERTEBRAL DISC DEGENERATION (diagnosis of Degenerative Narrowing on C5-6). On an unknown date, the patient experienced INSOMNIA (could not sleep nor able to change the positions). At the time of the report, INTERVERTEBRAL DISC DEGENERATION (diagnosis of Degenerative Narrowing on C5-6), MOBILITY DECREASED (loss of mobility in arm (no notation of R or L arm)), INSOMNIA (could not sleep nor able to change the positions), RASH (Rashes began on both arms), ARTHRALGIA (felt pain in both shoulders around spine), PAIN (Pain level max at 10/10 when patient was on medications) and PAIN (pain level lowered to 6/10 when patient took medications) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Apr-2021, X-ray: degenerative narrowing on c5-6 Degenerative Narrowing on C5-6..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 07Apr2021, patient saw Health Care Provider and X-ray was ordered on the same day with the diagnosis of Degenerative Narrowing on C5-6. MRI is on order.  Treatment medication reported includes : Ibuprofen 600mg 1 tablet 3 times a day, Gabapentin 100mg 1 capsule 3 times a day, Cyclobenzaprine 5mg 2 tablets at bedtime.
pt recv vax 22JUL97 & immed p/vax exp pain in arm;approx 10min later exp swelling redness, & itching;pt was seen @ local ER was given epi & DPH;h/a;
Patient reported that later that same evening her arm got swollen, red, and painful around the injection site. 8pm is an approximate time the patient reported her symptoms occurred the evening after she received the shot.
Flu like symptoms; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 20Dec2021 15:30 (Lot number: 330308D) at the age of 30 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Stone fruit allergy" (unspecified if ongoing), notes: Stone fruit allergy. There were no concomitant medications. Vaccination history included: Bnt162b2 (Name of Drug as: Pfizer, Dose Number: 2 Batch/Lot No: EW0178 Location of, injection: Arm Left), administration date: 07Jun2021, when the patient was 29 years old, for COVID-19 Immunization; Bnt162b2 (Name of Drug as: Pfizer, Dose Number: 1 Batch/Lot No: EW0177 Location of, injection: Arm Left), administration date: 17May2021, when the patient was 29 years old, for COVID-19 Immunization. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious) with onset 21Dec2021 10:00, outcome "recovered", described as "Flu like symptoms". Therapeutic measures were not taken as a result of influenza like illness. No follow-up attempts are possible. No further information is expected.  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.
Numbness, tingling in arms, legs and feet after 1st dose of vaccine in March 2021. The condition became worse and more frequent after 2nd dose in April 2021. I was seen by my primary care doctor and prescribed Gabapentin. Condition did not improve. Went to neurologist in September 2021 and diagnosed with neuropathy and carpal tunnel. Same side effects recurred again after 3rd dose booster in December 2021.
Patient received Tdap vaccine at 09:00am on 3-26-08.  She states that at 7:00pm that evening she experienced tightness in chest and throat, and coughing lasting several minutes.  She took Benadryl and relaxed and the episode resolved.
Inguinal hernia with strangulation and Open right inguinal hernia repair with mesh. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
ADVERSE EVENT NOT SPECIFIED; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced adverse event not specified. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from adverse event not specified. This report was non-serious.
6 month old female patient experienced head bobbing and some eye rolling within 12 hours after she received her third dose of Daptacel and Ipol on 08/25/2005.  The patient's alertness decreased with these incidents.  The patient had an MRI performed with normal results.  At the time of the report, the reporter stated the symptoms were improving, but they still persist.   Follow up information received on 12/05/2005.  Per responsible physician the patient had no pre-existing medical conditions or allergies and had no illness at the time of the vaccination.  As per reporter, the patient had recovered from reaction from dose 3 as of 11/29/2005.
Information has been received from a consumer referring to his 69 year old wife with iodine allergy. The patient's medical history included hormone replacement therapy. On 14-DEC-2015 the patient was vaccinated with PNEUMOVAX 23 (single 0.5 ml dose) intramuscularly. Concomitant therapy included unspecified hormone replacement therapy medication. On the same day, after receiving PNEUMOVAX 23, the patient experienced pain at the injection site and itching all over her body. She was also in pain. The patient sought medical attention via calling the physician's office. The patient used her personal unspecified prescription anti itch cream. Annual physical unspecified lab/diagnostic studies were performed (results unspecified). Therapy with PNEUMOVAX 23 was also reported as continued. The outcome of the events was reported as not recovered/not resolved. Additional information has been requested.
I had excruciating pain during the injection that the nurse explained that sometimes is normal. About an hour after I left home, my left shoulder started stiffening, pain 10/10, and I could not take my breath from the pain. I took tylenol and motrin, which barely helped me sleep through the night. My left should is in so much pain, I cannot move it and I have limited motion with a lot of pain that is not going away. My shoulder is disabled. I have no ability to have normal motion.
HCP administered expired vaccine to the patient, after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (HCP administered expired vaccine to the patient, after the manufacture date of expiration) in a 58-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 08-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (HCP administered expired vaccine to the patient, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (HCP administered expired vaccine to the patient, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  It was unknown when the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: The live follow-up information was received on 08-Jun-2022 which contains non-significant information.
Administered a vaccine that has been refrozen; A spontaneous report was received from a nurse concerning a 63-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and was administered with vaccine that has been refrozen.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 28 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot: 025J20-2A) intramuscularly in the right deltoid for prophylaxis of COVID-19 infection.  On 31 Dec 2020, the nurse reported she had been storing the mRNA-1273 vaccines at -20 degrees Celsius but discovered that prior to the vaccine administration facility receiving the vaccines on 24 Dec 2020, they had been stored at 38.2 degrees Fahrenheit at another facility. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event, administered with vaccine that has been refrozen, was considered resolved on 28 Dec 2020. .; Reporter's Comments: This report refers to a case of administered a vaccine that has been refrozen for mRNA-1273, lot # 025J20-2A. There were no reported adverse events associated with this case of administered a vaccine that has been refrozen.
Cried unconsolably from 2PM-6PM after shots. Then was fine. No treatment.
Greater amount of tightnessin breath; Heart palpitation; Pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Greater amount of tightnessin breath) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Greater amount of tightnessin breath) (seriousness criterion hospitalization), PALPITATIONS (Heart palpitation) and PAIN (Pain). At the time of the report, DYSPNOEA (Greater amount of tightnessin breath), PALPITATIONS (Heart palpitation) and PAIN (Pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Troponin increased: high Troponin levels high 600's.         Reporter did not allow further contact
Pt returned with mom to county health dept with redness, swelling, and warmth to left arm near varicella vaccine site. Mom reports using cool compresses & Ibuprofen. Pt with no distress. Instructed to see doctor and call with updates. Mom returned call to confirm pt saw urgent care MD & received meds.
Asthmatic problems; Cough; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 15-Apr-2021. The most recent information was received on 04-Aug-2021 and was forwarded to Moderna on 04-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ASTHMA (Asthmatic problems) and COUGH (Cough) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, COPD and Seasonal allergy.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced ASTHMA (Asthmatic problems) and COUGH (Cough). At the time of the report, ASTHMA (Asthmatic problems) and COUGH (Cough) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. Treatment for the event include nebulizer solution.   This case was linked to US-MODERNATX, INC.-MOD-2021-077836 (E2B Linked Report).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Sig Fup received- event outcome/further fup declined; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077836:
A LITTLE TIRED THE NEXT DAY; This spontaneous report received from a consumer via a company representative through a social media) concerned a male of an unspecified age, race and ethnicity The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: unknown and expiry: unknown) dose was not reported, 1 total, administered on an unspecified date for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. The drug latency period was 1 day. No concomitant medications were reported.  On an unspecified date, the patient was a little tired next day following the first dose of the vaccination (dose number in series 1).  The patient received additional booster dose of covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: unknown and expiry: unknown) dose was not reported, 1 total, administered on an unspecified date for covid-19 prophylaxis.  The patient had no adverse events following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 2). The reporter stated that "My husband and I both had the J&J vaccine. A little tired the next day after the first shot, nothing after the second shot. Are we supposed to get more shots". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of a little tired the next day was not reported. This report was non-serious. This case, from the same reporter is linked to 20221129570.
p/vax pt exp serum sickness; urticaria over entire body; swelling dorsum hands; tx: prednisone, Zyrtec
getting my flu shots my whole life; had the flu twice in my life; Initial information received on 24-Dec-2021 regarding an unsolicited valid non-serious case received from a consumer/non-hcp via global digital media.  This case involves an unknown age and gender patient who reported getting my flu shots my whole life; had the flu twice in my life, while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (dose, formulation, lot number not reported via unknown route in unknown administration site) as prophylactic vaccination.  On an unknown date ,the patient developed a non-serious event "getting my flu shots my whole life; had the flu twice in my life" (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported" I have been getting my flu shots my whole life I am in my 60s now I have had the flu twice in my life I've had my covid shots and also boosters I've also had overseas medical type of shots depending on what part of the world I was going to and what to look out for in different parts of the world and to be prepared for what possible exposures you might have there."   Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (getting my flu shots my whole life; had the flu twice in my life).  At time of reporting, the outcome was Unknown for the event getting my flu shots my whole life; had the flu twice in my life.